Adding vitamin D3 to the dipeptidyl peptidase-4 inhibitor saxagliptin has the potential to protect β-cell function in LADA patients: A 1-year pilot study (Q89643200)
Jump to navigation
Jump to search
scientific article published on 10 February 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adding vitamin D3 to the dipeptidyl peptidase-4 inhibitor saxagliptin has the potential to protect β-cell function in LADA patients: A 1-year pilot study |
scientific article published on 10 February 2020 |
Statements
Adding vitamin D3 to the dipeptidyl peptidase-4 inhibitor saxagliptin has the potential to protect β-cell function in LADA patients: A 1-year pilot study (English)
Ziwei Zhang
Xiang Yan
Chao Wu
Xieyi Pei
Xia Li
Xiangbing Wang
Xiaohong Niu
Hongwei Jiang